Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

SHA:600332 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 18.81B CNY in the quarter ending June 30, 2026, a decrease of -2.83%. This brings the company's total for the last twelve months to 77.91B, up 2.81% year-over-year. In the year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B with 3.55% growth. That makes Guangzhou Baiyunshan Pharmaceutical Holdings Company the 1,289th largest company in the world by revenue and 119th in China.

• Revenue (ttm): 77.91B
• Revenue Growth: +2.81%
• P/S Ratio: 0.39
• Revenue / Employee: 2.96M
• Employees: 26,365
• Market Cap: 29.84B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Commercial 58.17B 67.9%
• Natural Beverage 9.73B 11.4%
• Modern Chinese Medicine 7.52B 8.8%
• Others 6.48B 7.6%
• Chemical Pharmaceutical Technology 3.77B 4.4%

By Geography

Chart

• China 77.36B 99.6%
• Other Countries/Regions 294.31M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHA:600332 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	77.66B	2.66B	3.55%
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error